Status:
RECRUITING
Observational Study of Iris Tumors
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Iris Tumor
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes wit...
Eligibility Criteria
Inclusion
- Inclusion Criteria for tumor group:
- Eyes with diagnosis of melanotic or amelanotic iris tumors
- Inclusion Criteria for healthy control group:
- Eyes without iris defects or lesions
- Exclusion Criteria (both groups):
- Inability to give informed consent
- Inability to maintain stable fixation for OCT imaging
- Inability to commit to required study visits
- Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
- Mature cataracts if found to limit visual potential to worse than 20/40
Exclusion
Key Trial Info
Start Date :
June 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03809585
Start Date
June 20 2018
End Date
December 1 2027
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239